PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Confirmatory trials are essential in the case of Accelerated Approval to confirm that the drug continues to offer the ...

The FDA has published ... underrepresented populations in clinical trials to help improve the data we have about patients who will use the medical products if approved.” The guidance is out ...

Elon Musk’s Neuralink company has said it has implanted its wireless brain implant device into a human being for the first time, following FDA approval of clinical trials last year. In a series ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

Luye Pharma Group has received approval from China’s National Medical Products Administration to conduct clinical trials for LY03021, a new innovative antidepressant designed to treat Major ...

The FDA approval was based on data from the company’s ongoing global clinical trial, which provided safety and efficacy ...

Cross Trails BESS to provide energy and ancillary services to support renewable energy production and improve grid resiliency in the Electric Reliability Council of Texas (ERCOT) region Upcoming ...

PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...